As #ProstateCancerAwareness month approaches and #TeamNYPrunsNYC trains for the TCS New York City Marathon, please donate to #ProstateCancerResearch with WCM Prostate SPORE at NewYork-Presbyterian and Weill Cornell Medicine here: give.nyp.org/goto/MensHealt… Thanks to corporate charity sponsors: W. P. Carey Inc. and ViewRay.

Join Team NewYork-Presbyterian for the ZERO - The End of Prostate Cancer Walk/Run on Sunday, September 17, 2022. Full weekend of events...stay tuned.
support.zerocancer.org/goto/NYP

As #MensHealthAwareness month closes and #NYPrunsNYC trains for the TCS New York City Marathon, please donate to #ProstateCancerResearch collaborating with WCM Prostate SPORE at NewYork-Presbyterian
and Weill Cornell Medicine here: give.nyp.org/goto/MensHealt…
Thanks to corporate charity sponsors:W. P. Carey Inc. and ViewRay

Donate here: give.nyp.org/site/TR/NewYor…
Tim McClure Andrea Sboner, PhD (he/him) Luigi Marchionni - We're hiring!

55% fatigue and 36% gynecomastia. In AS patients.

Why do we keep trying to escalate when the data CLEARLY say we should continue to de-escalate?

💥On behalf of co-investigators Clare Tempany MD Adam Kibel Quoc-Dien Trinh, MD MBA and co-senior authors Geoffrey A. Sonn, MD Peji Ghanouni, we are excited to share the FINAL results of MR-guided HIFU Focal Therapy in men with intermediate risk prostate cancer. 1/8 thelancet.com/journals/lanon…

June is #MensHealthMonth .

As #NYPrunsNYC trains for the 2022 TCS New York City Marathon, please donate for #MensHealthAwareness and #ProstateCancerResearch collaborating with WCM Prostate SPORE at NewYork-Presbyterian and Weill Cornell Medicine here: give.nyp.org/goto/MensHealt…
Tim McClure Andrea Sboner, PhD (he/him) Luigi Marchionni - We're hiring!

Weill Cornell Medicine/NewYork-Presbyterian is two-thirds enrolled to a trial in the post-op setting comparing side effects of 20 vs. 5 sessions for #ProstateCancer using real-time MRI-guided RT. Partnering with PRIMR to increase awareness. ViewRay #ASCO22 #ASCOiSpy vimeo.com/716717054

⁦WCM Urology⁩ and ⁦Weill Cornell Medicine⁩ we are changing medicine!

Steve Kerr on today's tragic shooting in Uvalde, Texas.

Tremendous effort by patient advocates, industry partners ViewRay, Decipher by Veracyte, and Lantheus. Opening soon at collaborating institutions UCLA Jonsson Comprehensive Cancer Center, GenesisCare, and Penn State Health. Thanks to PRIMR for patient facing video: jcto.weill.cornell.edu/open_clinical_…

.Weill Cornell Medicine is leading a new international #ClinicalTrial to compare the side effects between five or two radiation treatments for patients with #ProstateCancer using real-time MRI-guided radiation technology. Learn more: bit.ly/3l0mGA0

Congratulations Joseph Osborne on your well deserved induction! WCM Molecular Imaging and Therapeutics Weill Cornell Medicine Augustine M.K. Choi

Congratulations to you and your 2022 fellow inductees into American College of Radiology fellowship, Joseph Osborne! #ACR2022

Today marks a major step forward for precision oncology. WCM Molecular Imaging and Therapeutics administered their first Pluvicto Treatment today.Pluvicto is the first FDA approved radioligand therapy for patients with prostate cancer. Weill Cornell Medicine Joseph Osborne @LadyTor08133763

Dear radiologists: please dont sabotage small renal mass active surveillance by doing this (especially in an older, frail patient with other active issues)

Congratulations Sam LaRussa on winning best GU poster at #SIO2022 ! Technique of same day transarterial embolization followed by microwave ablation has proven very effective! Looking forward to seeing results in print! #irad SIO Yale IR Weill Cornell Medicine Interventional Radiology Tim McClure

Imaging: Prostate Cancer youtu.be/cf9h-8tPqgM via YouTube

Joseph Osborne highlighting the importance of #diversity in clinical trials leading to #radhealthequity

Neil H Bander MD Scott Tagawa Himanshu Nagar Augustine M.K. Choi Weill Cornell Medicine ZERO - The End of Prostate Cancer WCM Molecular Imaging and Therapeutics WCM Urology